|
Market Closed -
Japan Exchange
09:30:00 28/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 5,800.00 JPY | -0.15% |
|
+0.62% | +19.96% |
| 08-29 | US FDA approves Takeda, Protagonist's drug for rare blood cancer | RE |
| 08-29 | Takeda's Mimrylo Gets FDA Approval to Treat Blood Cancer Condition | DJ |
Chart: Technical Analysis
Stock exchange
Japan Exchange
4502 5,800.00 ¥
-0.15%
17.5B
¥
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Japan Exchange
| 4502 | 5,800.00JPY | -0.15% | 17.5B ¥ | |
Tradegate
| TKD | 31.14EUR | -1.05% | 19.77K € | |
|
OTC Markets
| TKPHF | 36.62USD | -3.33% | 6.34K $ | |
|
Deutsche Boerse AG
| TKD | 30.91EUR | -0.77% | 3.09K € | |
|
Börse Stuttgart
| TKD | 31.01EUR | -0.77% | 0 € | |
|
Boerse Muenchen
| TKD | 31.26EUR | -0.48% | 0 € | |
|
Wiener Boerse
| TKD | 31.26EUR | +0.03% | 0 € | |
NYSE
| TAK | 18.03USD | 0.00% | 32.63M $ | |
|
CBOE
| TAK | 18.04USD | 0.00% | 912K $ | |
|
London S.E.
| 0A87 | 15.80USD | +0.83% | 15.8K $ | |
|
Deutsche Boerse AG
| TKDA | 15.30EUR | -1.29% | 0 € | |
|
Börse Stuttgart
| TKDA | 15.40EUR | 0.00% | 0 € | |
|
Tradegate
| TKDA | 15.60EUR | +0.65% | 0 € | |
|
Boerse Muenchen
| TKDA | 15.50EUR | 0.00% | 0 € | |
Sao Paulo
| TAKP34 | 93.69BRL | +22.76% | 281.07 R$ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 5,890 | 5,890 | 5,840 |
| Spread/Res. | -1.53% | -1.53% | -0.68% |
| Spread/Supp. | +5.21% | +22.16% | +39.66% |
| Support | 5,513 | 4,748 | 4,153 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 4502 Stock
- Charts Takeda Pharmaceutical Company Limited
Select your edition
All financial news and data tailored to specific country editions
